6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine structure
|
Common Name | 6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine | ||
|---|---|---|---|---|
| CAS Number | 2095417-61-9 | Molecular Weight | 592.60 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C33H28N4O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine |
|---|
| Description | 6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C33H28N4O7 |
|---|---|
| Molecular Weight | 592.60 |
| InChIKey | WVYMZTDRHINGHR-LLUXNYMTSA-N |
| SMILES | Cc1ncnc2c1ncn2C1OC(COC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C1(C)OC(=O)c1ccccc1 |